Dasabuvir

Brand name: Viekira Pak

DILI Likelihood

Score B — Known Hepatotoxin

This drug is known or highly likely to cause idiosyncratic liver injury and has a characteristic signature.

Between 12 and 50 cases including small case series have been described in the medical literature.

Classification

Primary class Antimicrobial

Secondary class Antiviral: HCV

FDA approval 2014

No article link available. Search directly at livertox.nih.gov.